poisar

Stocks · News reference

H.C. Wainwright Maintains Hold Rating on BioMarin Pharmaceutical

Fiscal.ai

Analyst Mitchell Kapoor of H.C. Wainwright has maintained a 'Hold' rating and a $60 price target for BioMarin Pharmaceutical Inc.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading